论文部分内容阅读
目的:分析总结肝脏囊腺瘤(BCA)和囊腺癌(BCAC)临床及放射学特点,预测患者无瘤生存时间及总的生存率。背景:肝胆管囊腺瘤和囊腺癌是肝脏一种少见的肿瘤,尚无其临床特点及预后的多中心研究。方法:收集1984~2013年10个大的国际肝胆外科中心248例行外科手术治疗的肝囊腺瘤和囊腺癌患者的临床资料、诊疗经过及随访信息等,分析总结两者的临床特点及预后。结果:248例BCA或BCAC患者术前的胆红素、CA199、CEA值分别为0.6 mg/dL、15.0 U/mL、2.7 ng/mL。术前主要的影像学检查包括增强CT、MR,
Objective: To analyze the clinical and radiological characteristics of liver cystadenocarcinoma (BCA) and cystadenocarcinoma (BCAC) and predict the survival time and overall survival rate of patients without tumor. Background: Hepatic biliary cystadenoma and cystadenocarcinoma, a rare tumor in the liver, have not yet had a multicenter study of their clinical features and prognosis. Methods: The clinical data, diagnosis, treatment and follow-up information of 248 patients with hepatic cystadenoma and cystadenocarcinoma who underwent surgical treatment in 248 large international hepatobiliary surgery centers from 1984 to 2013 were collected and analyzed. Prognosis. Results: The preoperative bilirubin, CA199, CEA values of 248 patients with BCA or BCAC were 0.6 mg / dL, 15.0 U / mL and 2.7 ng / mL, respectively. The main preoperative imaging studies include enhanced CT, MR,